All AbMole products are for research use only, cannot be used for human consumption.
Silodosin (Rapaflo) is an α1-adrenoceptor antagonist with high uroselectivity. It causes practically no orthostatic hypotension (in contrast to other α1 blockers). Since Silodosin is a highly selective inhibitor of the α1A adrenergic receptor, it causes practically no orthostatic hypotension (in contrast to other α1 blockers). On the other hand, the high selectivity seems to cause more problems with ejaculation.
Molecular Weight | 495.53 |
Formula | C25H32F3N3O4 |
CAS Number | 160970-54-7 |
Solubility (25°C) | DMSO 90 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Gianluigi Califano, et al. Focus on Silodosin: Pros and Cons of Uroselectivity
[2] No authors listed. Silodosin
[3] Luca Villa, et al. Silodosin: An Update on Efficacy, Safety and Clinical Indications in Urology
[4] No authors listed. Aust Prescr. Silodosin for benign prostatic hypertrophy
Related Adrenergic Receptor Products |
---|
Indoramin
Indoramin is a selective α1A-adrenoceptor antagonist. |
Ro 363 hydrochloride
Ro 363 hydrochloride is a potent and highly selective β1-adrenoceptor agonist. Ro 363 hydrochloride is also an effective inotropic stimulant. Ro 363 hydrochloride is a cardiovascular modulator that reduces diastolic blood pressure and pronounces increases in myocardial contractility. |
Phentolamine
Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. |
Dipivefrin
Dipivefrin is a potent adrenergic agonist. |
HOKU-81
HOKU-81 (4-Hydroxytulobuterol) is one of the metabolites of Tulobuterol. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.